Effect of a re-sss lipiodol/i-lipiodol mixture, re-sss lipiodol alone or i-lipiodol alone on the survival of rats with hepatocellular carcinoma

Nuclear Medicine Communications

Volumn 27, Issue 4, 2006, Pages 363-369

  Garin, Elienne ^a   Rakotonirina, Hervé ^a   Lejeune, Florence ^a   Denizot, Benoit ^a   Roux, Jerome ^a   Noiret, Nicolas ^a   Mesbah, Habiba ^a   Herry, Jean Yues ^a   Bourguet, Patrick ^a   Lejeune, Jean Jacques ^a  

^a CENTRE EUGÈNE MARQUIS   (France)

Author keywords

Animal study; Liver neoplasm; Metabolic radiotherapy

Indexed keywords

IODINATED POPPYSEED OIL; IODINATED POPPYSEED OIL I 131; LIPIODOL RE 131; LIPIODOL RE 188; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; ORGANOMETALLIC COMPOUND; RADIOACTIVE IODINE; RHENIUM SSS LIPIODOL; RHENIUM-SSS-LIPIODOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; LIVER CELL CARCINOMA; LOG RANK TEST; NONHUMAN; NONPARAMETRIC TEST; RAT; SURVIVAL TIME; TREATMENT OUTCOME; ANIMAL; COMPARATIVE STUDY; DRUG COMBINATION; LIVER TUMOR; PROGNOSIS; SPRAGUE DAWLEY RAT; SURVIVAL; SURVIVAL RATE;

ANIMALS; CARCINOMA, HEPATOCELLULAR; DRUG COMBINATIONS; FEMALE; IODINE RADIOISOTOPES; IODIZED OIL; LIVER NEOPLASMS; ORGANOMETALLIC COMPOUNDS; PROGNOSIS; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33746922013     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200604000-00008     Document Type: Article

References (33)

1. Bosch FX, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis 1999; 19:271-285.
2. Garin E, Bourguet P. Use of labelled lipiodol in the treatment of hepatic tumours. In: Ell PJ, Gambhir SS (editors): Nuclear Medicine in Clinical Diagnosis and Treatment, Volume 1, 3rd edition. Edinburgh: Elsevier Science; 2004, pp. 473-483.
3. 188Re-TDD, for the treatment of liver cancer. Nucl Med Biol 2001; 28:197-204.
4. 188Re-HDD/lipiodol therapy for hepatocellular carcinoma: a phase I clinical trial. J Nucl Med 2005; 46:60-66.
5. 188Re-HDD/lipiodol for treatment of hepatocellular carcinoma: a feasibility study in patients with advanced cirrhosis. J Nucl Med 2005; 46:1326-1332.
6. 188Re-lipiodol: preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma. Nucl Med Commun 2004; 25:691-699.
7. 188Re-SSS lipiodol following injection into hepatic artery of healthy pig. Eur J Nucl Med Mol Imaging 2004; 31:542-546.
8. 188Re-SSS lipiodol: radiolabelling and biodistribution following injection into the hepatic artery of rats bearing hepatoma. Nucl Med Commun 2004; 25:1007-1013.
9. Raoul JL, Guyader D, Bretagne JF, Duvauferrier R, Bourguet P, Bekhechi D, et al. Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support. J Nucl Med 1994; 35:1782-1787.
10. 131I-labeled iodized oil in the treatment of hepatocellular carcinoma. Hepatology 1997; 26:1156-1161.
11. 188rhenium-HDD-labeled iodized oil in rabbit VX2 liver tumour. J Vasc Interv Radiol 2004; 15:1121-1128.
12. O'Donoghue JA, Bardiès M, Wheldon TE. Relationship between tumour size and curability for uniformly targeted therapy with beta-emitting radionuclides. J Nucl Med 1995; 36:1902-1909.
13. 90Y. Radiother Oncol 1991; 21:91-99.
14. Yoo HS, Park CH, Suh JH, Lee JT, Kim DI, Kim BS, Madsen MT. Radioiodinated fatty acid esters in the management of hepatocellular carcinoma: preliminary findings. Cancer Chemother Pharmacol 1989; 23(suppl):S54-S58.
15. Lui WY, Liu RS, Chiang JH, Lo JG, Lai KH, King KL, et al. Report of a pilot study of intra-arterial injection of I-131 Lipiodol for the treatment of hepatoma. Chin Med J (Taipei) 1990; 46:125-133.
16. Yoo HS, Lee JT, Kim KW, Kim BS, Choi HJ, Lee KS, et al. Nodular hepatocellular carcinoma. Treatment with subsegmental intraarterial injection of iodine 131-labeled iodized oil. Cancer 1991; 68:1878-1884.
17. Maini CL, Scelsa MG, Fiumara C, Tofany A, Sciuto R, Tipaldi L, et al. Superselective intra-arterial radiometabolic therapy with I-131 Lipiodol in hepatocellular carcinoma. Clin Nucl Med 1996; 21:221-226.
18. Wang SJ, Lin WY, Chen MN, Hsieh BT, Shen LH, Tsai ZT, et al. Biodistribution of rhenium-188 lipiodol infused via the hepatic artery of rats with hepatic tumours. Eur J Nucl Med 1996; 23:13-17.
19. 131I-labelled lipiodol on hepatocellular carcinoma of rat. Ann Acad Med 1986; 15:521-524.
20. Madsen MT, Park CH, Thakur ML. Dosimetry of iodine 131 ethiodol in the treatment of hepatoma. J Nucl Med 1988; 29:1038-1044.
21. 131I-lipiodol delivery on tumour uptake and response. Nucl Med Commun 2003; 24:391-396.
22. 90Y-microspheres on liver tumours: comparison of intra-tumoural injection method and intra-arterial injection method. J Nucl Med 2000; 41:1892-1897.
23. Garin E, Denizot B, Roux J, Noiret N, Lepareur N, Moreau M, et al. Description and technical pitfalls of a hepatoma model and of intra-arterial injection of radiolabelled lipiodol in the rat. Laboratory Animals 2005; 39:314-320.
24. Brans B, Van Laere K, Gemmel F, Defreyne L, Vanlangenhove P, Troisi R, et al. Combined iodine-131 lipiodol therapy with low-dose cisplatin as radiosensitiser: preliminary study results in hepatocellular carcinoma. Eur J Nucl Med 2002; 29:928-932.
25. 131I) in the treatment of hepatocellular carcinoma (HCC): results of a phase II trial. J Clin Oncol 2002; 21:563.
26. De Baere T, Zhang X, Aubert B, Harry G, Lagrange C, Ropers J, et al. Quantification of tumour uptake of iodized oils and emulsions of iodized oils: experimental study. Radiology 1996; 201:731-735.
27. Garin E, Denizot B, Roux J, Noiret N, Lepareur N, Moreau M, et al. Effect of stabilized lipiodol emulsion on experimentally induced hepatocellular carcinoma in rats. J Vasc Intervent Radiol 2005; 16:841-848.
28. Burton MA, Gray BN, Self GW, Heggie JC, Towensend PS. Manipulation of experimental rat and rabbit liver tumour blood flow with angiotensin II. Cancer Res 1985; 45:5390-5393.
29. Burton MA, Gray BN, Coletti A. Effect of angiotensin II on blood flow in the transplanted sheep squamous cell carcinoma. Eur J Cancer Clin Oncol 1988; 24:1373-1376.
30. 131I therapy and total body irradiation for treatment of disseminated tumours of differing radiosensitivity. Int J Radiat Oncol Biol Phys 1993; 27:323-330.
31. Towu E, Boxer G, Begent R, Zweit J, Spitz L, Hobbs K, Winslet M. In-vitro uptake of radioactive lipiodol I-131 and I-125 by hepatoblastoma: implications for targeted radiotherapy. Pediatr Surg Int 2001; 17:609-613.
32. 177Lu-labelled somatostatin analogues for radionucleide therapy. Eur J Nucl Med 2002; 29(suppl 1):S119.
33. Kraczynski J, Hansson G, Remotti H, Wallerstedt S. Spontaneous regression of HCC. Histopathology 1998; 32:147-150.